B6.129S2-P2ry1tm1Gac/Orl

Status

Available to order

EMMA IDEM:00207
Citation informationRRID:IMSR_EM:00207 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129S2-P2ry1tm1Gac/Orl
Alternative nameKO-P2Y1
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolP2ry1tm1Gac
Gene/Transgene symbolP2ry1

Information from provider

ProviderC GACHET
Provider affiliationINSERM, Strasbourg
Phenotypic informationInactivation of the P2ry1 gene. The coding sequence was interrupted by insertion of a PGK-neo-poly(A) cassette. Defective platelet aggregation and increased resistance to thrombosis.
References
  • Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.;Léon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave J P, Gachet C, ;1999;The Journal of clinical investigation;104;1731-7; 10606627

Information from EMMA

Archiving centreCNRS-TAAM – Typing and Archiving of Animal Models, Orléans, France

Disease and phenotype information

MGI phenotypes (allele matching)
  • decreased platelet aggregation / MGI
  • abnormal blood coagulation / MGI
  • increased bleeding time / MGI
MGI phenotypes (gene matching)
  • abnormal blood coagulation / MGI
  • abnormal thrombolysis / MGI
  • increased bleeding time / MGI
  • decreased platelet aggregation / MGI

Literature references

  • Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.;Léon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave J P, Gachet C, ;1999;The Journal of clinical investigation;104;1731-7; 10606627

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).